npj Vaccines
Q1 Journal
Open Access
Journal
Country
United Kingdom
Western Europe
Subject Area and Category
Immunology and Microbiology
└
Immunology
Q1
└
Infectious Diseases
Q1
└
Pharmacology
Q1
Publisher
SJR 2025
2.282
Q1
SJR Score
H-Index
63
Citations / Doc (2yr)
6.81
Total Docs. (latest)
264
Total Citations (3yr)
3,862
Publication type
Journals
ISSN
20590105
Coverage
2016-2026
Journal Rank
#1,118
Subject Categories
Immunology
Q1
Infectious Diseases
Q1
Pharmacology
Q1
Pharmacology (medical)
Q1
Aims & Scope
npj Vaccines is a multidisciplinary journal that is dedicated to publishing the finest and high-quality research and development on human and veterinary vaccines, including:
discovery and basic science,
nonclinical development of vaccines,
biodefense vaccine,
AIDS vaccine,
vaccine formulation,
vaccine adjuvants and conjugate vaccines,
cancer/oncology vaccines,
clinical evaluation of vaccines,
vaccine safety,
regulatory science,
conventional and non-conventional vaccines,
live, attenuated vaccines,
inactivated vaccines,
subunit vaccines,
toxoid vaccines,
DNA vaccines,
recombinant vector vaccines.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Embase
Detailed Metrics
| Total Docs. (latest) | 264 |
| Total Docs. (3 years) | 590 |
| Total Refs. | 14,514 |
| Total Citations (3 years) | 3,862 |
| Citable Docs. (3 years) | 573 |
| Citations / Doc. (2 years) | 6.81 |
| Ref. / Doc. | 54.98 |
| % Female | 46.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.